AIRLINK 72.59 Increased By ▲ 3.39 (4.9%)
BOP 4.99 Increased By ▲ 0.09 (1.84%)
CNERGY 4.29 Increased By ▲ 0.03 (0.7%)
DFML 31.71 Increased By ▲ 0.46 (1.47%)
DGKC 80.90 Increased By ▲ 3.65 (4.72%)
FCCL 21.42 Increased By ▲ 1.42 (7.1%)
FFBL 35.19 Increased By ▲ 0.19 (0.54%)
FFL 9.33 Increased By ▲ 0.21 (2.3%)
GGL 9.82 Increased By ▲ 0.02 (0.2%)
HBL 112.40 Decreased By ▼ -0.36 (-0.32%)
HUBC 136.50 Increased By ▲ 3.46 (2.6%)
HUMNL 7.14 Increased By ▲ 0.19 (2.73%)
KEL 4.35 Increased By ▲ 0.12 (2.84%)
KOSM 4.35 Increased By ▲ 0.10 (2.35%)
MLCF 37.67 Increased By ▲ 1.07 (2.92%)
OGDC 137.75 Increased By ▲ 4.88 (3.67%)
PAEL 23.41 Increased By ▲ 0.77 (3.4%)
PIAA 24.55 Increased By ▲ 0.35 (1.45%)
PIBTL 6.63 Increased By ▲ 0.17 (2.63%)
PPL 125.05 Increased By ▲ 8.75 (7.52%)
PRL 26.99 Increased By ▲ 1.09 (4.21%)
PTC 13.32 Increased By ▲ 0.24 (1.83%)
SEARL 52.70 Increased By ▲ 0.70 (1.35%)
SNGP 70.80 Increased By ▲ 3.20 (4.73%)
SSGC 10.54 No Change ▼ 0.00 (0%)
TELE 8.33 Increased By ▲ 0.05 (0.6%)
TPLP 10.95 Increased By ▲ 0.15 (1.39%)
TRG 60.60 Increased By ▲ 1.31 (2.21%)
UNITY 25.10 Decreased By ▼ -0.03 (-0.12%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
BR100 7,566 Increased By 157.7 (2.13%)
BR30 24,786 Increased By 749.4 (3.12%)
KSE100 71,902 Increased By 1235.2 (1.75%)
KSE30 23,595 Increased By 371 (1.6%)

ISLAMABAD: Provincial health departments, Health Care Commissions and Chief Drug Inspectors have been directed to develop a mechanism to ensure prescription of medicines in generic name.

Directions in this regard were issued to provinces in response to complaint received from the Prime Minister portal that some pharma firms give bribes to doctors for prescribing their trade names of medicines.

Director, Division of Pharmacy Services, Drug Regulatory Authority of Pakistan (DRAP), Dr Abdur Rashid said that provinces will develop mechanism that all doctors should prescribe medicines in generic name and retail pharmacy drugs will be dispensed by pharmacists.

The matter of registration of drugs on generic name basis has already been taken up by the concerned DRAP’s Division with relevant stakeholders in March 2021.

The directions of Director, Division of Pharmacy Services were issued on April 16 to ask the provincial authorities to take necessary measures for promoting generic prescribing practices.

He said that as misuse and overuse of antimicrobials was leading to Antimicrobial Resistance (AMR), there was dire need that all antimicrobials including antibiotics, antivirals, anti fungus and antimicrobials should be prescribed in generic name.

As per Punjab Drug Sale Rules 2007, medicines under Schedule B&D should be sold only on the prescription of doctor and dispensed by the pharmacist on retail pharmacy.

This issue has been discussed in 111th meeting of DRAP and decided that a proper mechanism should be developed by the provincial governments that all medicines should be prescribed only by the doctor and dispensed by pharmacists at retail pharmacy.

In August, 2021, provincial health departments, Healthcare Commissions, Chief Drug Inspectors and DG Health Pharmacy Services will conduct a meeting with Division of Pharmacy Services and strategy will be developed in their respective provinces in consultation with stakeholders like PPA, PMA, PCDA, PPMA, Pharma Bureau, and others that medicines will be prescribed by doctors in generic name and dispensed by pharmacists only at retail pharmacy.

Comments

Comments are closed.